Current Projects
 
Search
 

Home
Search for Projects
View Projects
Project Title
by Subject/Focus Area
by Board/Committee
by Major Unit
Provisional Committee Appointments Open for Formal Public Comments
by Last Update
Meeting Information
Conflict of Interest Policy
Committee Appointment Process
FAQ
  meetingview
More Project Information and to provide FEEDBACK on the Project

 Printer Friendly Version

Meeting Information


Project Title: Human Embryonic Stem Cell Research Advisory Committee

PIN: BLSX-K-05-04-A         

Major Unit:
Division on Earth and Life Studies
Institute of Medicine

Sub Unit:
Board on Life Sciences
Board on Health Sciences Policy

RSO:
Fagen, Adam

Subject/Focus Area:
Biology and Life Sciences; Health and Medicine; Policy for Science and Technology


First Meeting of the Human Embryonic Stem Cell Research Advisory Committee
July 6, 2006 - July 7, 2006
Keck Center
500 5th Street, NW
Washington D.C. 20001



If you would like to attend the sessions of this meeting that are open
to the public or need more information please contact:


Contact Name: Anne Jurkowski
Email: ajurkowski@nas.edu
Phone: 202-334-1442
Fax: 202-334-1289


Agenda:

July 6, 2006

2:00 p.m. Introduction to public session
RICHARD HYNES and ALTA CHARO, Committee Co-Chairs

2:10 p.m. Sponsor Perspective
• RICHARD L. SPROTT, Executive Director, The Ellison Medical Foundation

2:30 p.m. BREAK

2:45 p.m. Perspectives from other groups working on guidelines (20 min each)
• California Institute for Regenerative Medicine (CIRM):
BERNARD LO, Co-Chair, Scientific and Medical Accountability Standards Work Group, CIRM; Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco
• International Society for Stem Cell Research (ISSCR):
GEORGE Q. DALEY, Chair, International Human Embryonic Stem Cell Guidelines Task Force, and Vice President, ISSCR; Associate Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School; Associate Professor of Pediatrics, Children’s Hospital Boston and Dana Farber Cancer Institute


3:45 p.m. Panel discussion with representatives from scientific groups using the guidelines
• Association of American Medical Colleges: ANTHONY J. MAZZASCHI, Director of CAS Affairs and Senior Associate Vice President for Biomedical and Health Sciences Research
• Coalition for the Advancement of Medical Research (CAMR): SEAN TIPTON, President, CAMR; Director of Public Affairs, American Society for Reproductive Medicine
• Federation of American Societies for Experimental Biology (FASEB): LEO T. FURCHT, President, FASEB; Allen-Pardee Professor and Head, Department of Laboratory Medicine and Pathology, University of Minnesota
• Juvenile Diabetes Research Foundation International: ROBERT GOLDSTEIN, Chief Scientific Officer
• University of California, San Francisco: BERNARD LO, Professor of Medicine and Director of the Program in Medical Ethics, University of California, San Francisco
• Wisconsin Alumni Research Foundation (WARF): ELIZABETH L.R. DONLEY, General Counsel and Director of Business Development, WARF; General Counsel and Interim Executive Director, WiCell Research Institute; Managing Director and General Counsel, WiSys Technology Foundation, Inc.

5:15 p.m. Reception for committee members and guests
Second Floor Lobby



Closed Session Summary Posted After the Meeting

The following committee members were present at the closed sessions of the meeting:
R. Alta Charo
Richard O. Hynes
Eli Y. Adashi
Brigid L.M. Hogan
Marcia Imbrescia
Terry Magnuson
Linda B. Miller (via teleconference)
Jonathan D. Moreno
Stuart H. Orkin
Pilar Nicole Ossorio
E. Albert Reece
Joshua R. Sanes
Harold Shapiro
John E. Wagner
Jr.

The following topics were discussed in the closed sessions:
Overview of the Committee Process
Discussion of Bias and Conflict of Interest and Committee Composition and Balance
Overview of Stem Cell Research
Discussion of National Academies Guidelines for Human Embryonic Stem Cell Research and other stem cell research guidelines
Discussion of Statement of Task
Discussion of Committee Priorities and Procedures
Preliminary Symposium Planning

The following materials (written documents) were made available to the committee in the closed sessions:
Summary Data on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research. Institute of Medicine, 2006.

California Institute for Regenerative Medicine. Proposed Changes to California Code of Regulations section 100003. 7/5/06.

Date of posting of Closed Session Summary: July 10, 2006



© Copyright 2009 The National Academies. All rights reserved. Tel: 202.334.2000 Fax: 202.334.1800 Email: info@nas.edu